The MaternaWell Tray for PPH estimation now appears in key obstetric guidelines
The MaternaWell Tray is a polypropylene estimation device that is tucked under a mother's perineum postpartum to track blood use.
The tray, invented by Dr. Justus Hofmyer, in South Africa, is now widely used across the public and private sector in South Africa. Zimbabwe and Sierra Leone are two other countries leading the implementation of the tray.
Mention of the MATERNAWELL TRAY by name in the South African Obstetrics and Gynecology Association postpartum hemorrhage guidelines has helped to spread its uptake.
More recently, a 'tray' is mentioned in the FIGO/WHO/ICM Consolidated Postpartum Hemorrhage Guidelines published by in 2025.
The tray is also included in a Course entitled "Bleeding after birth: course on prevention, diagnosis and treatment of postpartum haemorrhage." (Jhpiego, FIGO, ICM, Laerdal, UNFPA, HRP, WHO).
The tray is calibrated at 100 mL intervals with more visible lines at 300 mL and 500 mL in each of two wells. Most importantly, blood flows over from the first measuring well into the second well at 500 mL, a critical visual signal for health professionals and family members alike.
The 5-minute training video for the MaternaWell Tray is found here. As one senior midwife said to us, "the flowover feature of the trays gives our midwives enhanced confidence in calling a hemorrhage a hemorrhage and quickly escalating the E-MOTIVE bundle."
Dejar un comentario
Los comentarios se aprobarán antes de mostrarse.
Ver artículo completo
Is it ethical to separate mother and infant just after birth?
Immediate skin to skin care means less than ten minutes after the infant takes its first breath, the infant, naked except for a diaper, spends at least one hour on the mother’s chest, against her skin. It is recommended that preterm and low birth weight kangaroo care involve prolonging contact beyond the first hour for at least 8 hours per day or as long as possible (up to 24 hours) per day
Hierro intravenoso en el segundo trimestre: una forma innovadora de abordar la anemia en el embarazo
" El tratamiento de primera línea de la anemia por deficiencia de hierro materna moderada con infusión de dosis única de hierro intravenoso da como resultado una menor incidencia de recién nacidos con bajo peso ( carboximaltosa férrica intravenosa frente a oral) y una mayor incidencia de alcanzar un estado no anémico materno sin el uso de hierro adicional o transfusión de sangre (carboximaltosa férrica intravenosa y derisomaltosa férrica frente a oral)."
